[Are proton pump inhibitors safe?].
Creutzfeldt
W
W
Zentrum Innere Medizin, Georg-August-Universität Göttingen.
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000818:Animals; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D015197:Carcinogenicity Tests; D005744:Gastric Acid / Q000378:metabolism*; D006801:Humans; D064747:Lansoprazole; D009152:Mutagenicity Tests; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000077402:Pantoprazole; D010295:Parietal Cells, Gastric / Q000187:drug effects; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000209:etiology; D011355:Prodrugs / Q000008:administration & dosage / Q000009:adverse effects*; D054328:Proton Pump Inhibitors; D013329:Structure-Activity Relationship; D013454:Sulfoxides / Q000008:administration & dosage / Q000009:adverse effects*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D011355:Prodrugs; D054328:Proton Pump Inhibitors; D013454:Sulfoxides; D064747:Lansoprazole; D000077402:Pantoprazole; D009853:Omeprazole
Sind Protonenpumpeninhibitoren sicher?